KIR3DL1 and leukemia: Examining the protective effects in HIV-1 dC couples revealed KIR/HLA mismatches between both partners, suggesting an HIV-1 protective mechanism orchestrated by alloreactive NK cells, whose usefulness has already been proven in the treatment of leukemia.